Thermo Fisher Scientific Balance Sheet
NYSE: TMOIndustrialsIndustrial Machinery/ComponentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Thermo Fisher Scientific financial position
At the end of fiscal 2025, Thermo Fisher Scientific reported total assets of $110.34 billion, up 13.4% from a year earlier against total liabilities of $56.93 billion. Shareholders' equity stood at $53.41 billion, or 48.4% of assets. The company held $9.85 billion in cash and equivalents against $39.38 billion of debt, a net debt position of $29.53 billion.
The current ratio (current assets divided by current liabilities) was 1.89, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.74.
Summary generated from market data by MetaCap's automated system. Methodology
Thermo Fisher Scientific balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 9.85B | 4.01B | 8.08B | 8.52B | 4.48B | 10.32B | 2.40B | 2.10B | 1.33B | 786.00M |
| Short-Term Investments | 253.00M | 1.56B | 3.00M | — | — | — | — | — | — | — |
| Receivables | 8.90B | 8.19B | 8.22B | 8.12B | 7.98B | 5.74B | 4.35B | 4.14B | 3.88B | 3.05B |
| Inventory | 5.42B | 4.98B | 5.09B | 5.63B | 5.05B | 4.03B | 3.37B | 3.00B | 2.97B | 2.21B |
| Total Current Assets | 28.71B | 22.14B | 24.59B | 25.23B | 20.11B | 21.96B | 11.89B | 10.63B | 9.42B | 7.02B |
| Property, Plant & Equipment | 10.56B | 9.31B | 9.45B | 9.28B | 8.33B | 5.91B | 4.75B | 4.17B | 4.05B | 2.58B |
| Goodwill | 49.36B | 45.85B | 44.02B | 41.20B | 41.92B | 26.04B | 25.71B | 25.35B | 25.29B | 21.33B |
| Intangible Assets | 15.84B | 15.53B | 16.67B | 17.44B | 20.11B | 12.69B | 14.01B | 14.98B | 16.68B | 13.97B |
| Total Assets | 110.34B | 97.32B | 98.73B | 97.15B | 95.12B | 69.05B | 58.38B | 56.23B | 56.67B | 45.91B |
| Accounts Payable | 3.62B | 3.08B | 2.87B | 3.38B | 2.87B | 2.17B | 1.92B | 1.61B | 1.43B | 926.00M |
| Short-Term Debt | 3.53B | 2.21B | 3.61B | 5.58B | 2.54B | 2.63B | 676.00M | 1.27B | 2.13B | 1.25B |
| Total Current Liabilities | 15.19B | 13.33B | 14.01B | 17.01B | 13.44B | 10.30B | 6.20B | 6.15B | 7.05B | 4.87B |
| Long-Term Debt | 35.85B | 29.06B | 31.31B | 28.91B | 32.33B | 19.11B | 17.08B | 17.72B | 18.87B | 15.37B |
| Total Liabilities | 56.93B | 47.77B | 52.00B | 53.12B | 54.27B | 34.53B | 28.70B | 28.64B | 31.26B | 24.37B |
| Shareholders' Equity | 53.41B | 49.58B | 46.73B | 43.98B | 40.79B | 34.51B | 29.68B | 27.59B | 25.41B | 21.54B |
| Retained Earnings | 59.16B | 53.10B | 47.36B | 41.91B | 35.43B | 28.12B | 22.09B | 18.70B | 15.91B | 13.93B |
| Total Debt | 39.38B | 31.27B | 34.92B | 34.49B | 34.87B | 21.73B | 17.75B | 18.99B | 21.01B | 16.63B |
| Net Cash (Debt) | -29.28B | -25.70B | -26.84B | -25.96B | -30.39B | -11.41B | -15.35B | -16.89B | -19.67B | -15.84B |
This table shows 10 annual periods of Thermo Fisher Scientific's balance sheet, from FY 2025 back to FY 2016, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow TMO's reporting calendar. What is a balance sheet?